Biotech · Public company · Nashville,, TN, US
Cumberland Pharmaceuticals Inc
Ticker CPIX · SEC CIK 0001087294
Track this companyFree. Adds Cumberland Pharmaceuticals Inc to your Dealase workspace and tells you when its record changes.
Clinical trials254 recruiting or active
Pipeline programs24From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availableNo recent cash burn filed
Pipeline24
- CefazolinPhase 3 · BacteremiaClinicalTrials.gov · fetched Nov 12, 2026
- DaptomycinPhase 3 · BacteremiaClinicalTrials.gov · fetched Nov 12, 2026
- Synthetic penicillinPhase 3 · BacteremiaClinicalTrials.gov · fetched Nov 12, 2026
- TelavancinPhase 3 · BacteremiaClinicalTrials.gov · fetched Nov 12, 2026
- TelavancinPhase 3 · Staphylococcal Skin InfectionClinicalTrials.gov · fetched Nov 12, 2026
- TelavancinPhase 3 · Bacterial PneumoniaClinicalTrials.gov · fetched Nov 12, 2026
- VancomycinPhase 3 · Staphylococcal Skin InfectionClinicalTrials.gov · fetched Nov 12, 2026
- VancomycinPhase 3 · Bacterial PneumoniaClinicalTrials.gov · fetched Nov 12, 2026
- VancomycinPhase 3 · BacteremiaClinicalTrials.gov · fetched Nov 12, 2026
- Atorvastatin injectionPhase 2 · HypercholesterolemiaClinicalTrials.gov · fetched Nov 12, 2026
- IfetrobanPhase 2 · Duchenne Muscular Dystrophy CardiomyopathyClinicalTrials.gov · fetched Nov 12, 2026
- IfetrobanPhase 2 · Portal HypertensionClinicalTrials.gov · fetched Nov 12, 2026
- Ifetroban Oral CapsulePhase 2 · Asthma, Aspirin-InducedClinicalTrials.gov · fetched Nov 12, 2026
- Ifetroban SodiumPhase 2 · Idiopathic Pulmonary FibrosisClinicalTrials.gov · fetched Nov 12, 2026
- Oral IfetrobanPhase 2 · Scleroderma, DiffuseClinicalTrials.gov · fetched Nov 12, 2026
- TelavancinPhase 2 · Infections, Gram-Positive BacterialClinicalTrials.gov · fetched Nov 12, 2026
- TelavancinPhase 2 · Gram-Positive Bacterial InfectionsClinicalTrials.gov · fetched Nov 12, 2026
- Vancomycin or antistaphylococcal penicillinPhase 2 · Infections, Gram-Positive BacterialClinicalTrials.gov · fetched Nov 12, 2026
- Vancomycin, nafcillin, oxacillin, or cloxacillinPhase 2 · Gram-Positive Bacterial InfectionsClinicalTrials.gov · fetched Nov 12, 2026
- telavancinPhase 1 · Kidney DiseasesClinicalTrials.gov · fetched Nov 12, 2026
- IbuprofenPainClinicalTrials.gov · fetched Nov 12, 2026
- Intravenous ibuprofenPainClinicalTrials.gov · fetched Nov 12, 2026
- VibativHospital Acquired Bacterial PneumoniaClinicalTrials.gov · fetched Nov 12, 2026
- VIBATIVPregnancyClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials25
- Imaging Acetadote Metabolism in GlioblastomaEARLY_PHASE1 · RECRUITING · started Jun 18, 2026ClinicalTrials.gov NCT07387666 · fetched Nov 12, 2026
- Telavancin Blood and Cerebrospinal Fluid Concentrations in Patients With External Ventricular DrainagePHASE4 · RECRUITING · started Jul 2, 2024ClinicalTrials.gov NCT06119061 · fetched Nov 12, 2026
- Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF)PHASE2 · RECRUITING · started Jan 31, 2024ClinicalTrials.gov NCT05571059 · fetched Nov 12, 2026
- Oral Ifetroban in Subjects With Duchenne Muscular DystrophyPHASE2 · COMPLETED · started Oct 19, 2020ClinicalTrials.gov NCT03340675 · fetched Nov 12, 2026
- Thromboxane Receptor Antagonist to Improve Endothelial FunctionPHASE2 · COMPLETED · started Sep 20, 2019ClinicalTrials.gov NCT03962855 · fetched Nov 12, 2026
- Ifetroban in Treating Patients With Malignant Solid Tumors at High Risk of Metastatic RecurrencePHASE2 · UNKNOWN · started Dec 12, 2018ClinicalTrials.gov NCT03694249 · fetched Nov 12, 2026
- Dose-ranging Efficacy and Pharmacokinetics Study of Intravenous Atorvastatin in Hypercholesterolemic PatientsPHASE2 · COMPLETED · started Aug 7, 2018ClinicalTrials.gov NCT03611010 · fetched Nov 12, 2026
- Safety and Pharmacokinetic Study of Intravenous Ibuprofen in Pediatric PatientsPHASE4 · COMPLETED · started Aug 8, 2017ClinicalTrials.gov NCT02583399 · fetched Nov 12, 2026
- Oral Ifetroban to Treat Aspirin Exacerbated Respiratory Disease (AERD)PHASE2 · COMPLETED · started Jul 17, 2017ClinicalTrials.gov NCT03028350 · fetched Nov 12, 2026
- Study to Assess Safety and Efficacy of Ifetroban for Treatment of Portal Hypertension in Cirrhotic PatientsPHASE2 · COMPLETED · started Mar 6, 2017ClinicalTrials.gov NCT02802228 · fetched Nov 12, 2026
- Oral Ifetroban to Treat Diffuse Cutaneous Systemic Sclerosis (SSc) or SSc-associated Pulmonary Arterial HypertensionPHASE2 · ACTIVE_NOT_RECRUITING · started Jan 1, 2017ClinicalTrials.gov NCT02682511 · fetched Nov 12, 2026
- Telavancin Pediatric PK Study (Ages >12 Months to 17 Years)PHASE1 · TERMINATED · started Dec 1, 2014ClinicalTrials.gov NCT02013141 · fetched Nov 12, 2026
- A Phase 3 Telavancin Staphylococcus Aureus (S. Aureus) Bacteremia TrialPHASE3 · TERMINATED · started Dec 1, 2014ClinicalTrials.gov NCT02208063 · fetched Nov 12, 2026
- Telavancin Observational Use Registry (TOUR)COMPLETED · started Nov 1, 2014ClinicalTrials.gov NCT02288234 · fetched Nov 12, 2026
- Surgical Surveillance Trial to Evaluate a Shortened Infusion Time of Intravenous IbuprofenPHASE4 · COMPLETED · started Jun 1, 2011ClinicalTrials.gov NCT01334957 · fetched Nov 12, 2026
- Surveillance Trial to Evaluate a Shortened Infusion Time of Intravenous IbuprofenPHASE4 · COMPLETED · started Jun 1, 2011ClinicalTrials.gov NCT01334944 · fetched Nov 12, 2026
- A Study to Evaluate the Effect of Renal Function on the Biological Activity of TelavancinPHASE1 · COMPLETED · started Dec 1, 2010ClinicalTrials.gov NCT01238796 · fetched Nov 12, 2026
- VIBATIV Pregnancy RegistryWITHDRAWN · started Nov 1, 2009ClinicalTrials.gov NCT01130324 · fetched Nov 12, 2026
- N-Acetylcysteine to Prevent Radiocontrast Nephropathy in Emergency Department PatientsPHASE2 · COMPLETED · started Oct 16, 2007ClinicalTrials.gov NCT00780962 · fetched Nov 12, 2026
- Comparison of Telavancin and Vancomycin for Hospital-acquired Pneumonia Due to Methicillin-resistant Staphylococcus AureusPHASE3 · COMPLETED · started Feb 1, 2005ClinicalTrials.gov NCT00107952 · fetched Nov 12, 2026
- Comparison of Telavancin and Vancomycin for Complicated Skin and Skin Structure Infections With a Focus on Methicillin-resistant Staphylococcus AureusPHASE3 · COMPLETED · started Feb 1, 2005ClinicalTrials.gov NCT00107978 · fetched Nov 12, 2026
- Comparison of Telavancin and Vancomycin for Complicated Skin and Skin Structure Infections With a Focus on Methicillin-resistant Staphylococcus AureusPHASE3 · COMPLETED · started Jan 1, 2005ClinicalTrials.gov NCT00091819 · fetched Nov 12, 2026
- Phase 2 Trial of TD-6424 (Telavancin) Versus Standard Therapy for Complicated Gram Positive Skin and Skin Structure Infections (Gram Positive cSSSI)PHASE2 · COMPLETED · started Feb 1, 2004ClinicalTrials.gov NCT00077675 · fetched Nov 12, 2026
- Telavancin for Treatment of Uncomplicated Staphylococcus Aureus BacteremiaPHASE2 · COMPLETED · started Aug 1, 2003ClinicalTrials.gov NCT00062647 · fetched Nov 12, 2026
- Phase 2 Trial of TD 6424 (Telavancin) Versus Standard Therapy for Complicated Gram Positive Skin and Skin Structure Infections (Gram Positive cSSSI)PHASE2 · COMPLETED · started Jun 1, 2003ClinicalTrials.gov NCT00061633 · fetched Nov 12, 2026
SEC filings12
- 8-K · 8-KSEC EDGAR · filed Nov 10, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Oct 26, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Oct 23, 2026 · fetched Nov 12, 2026
- 8-K/A · 8-K/ASEC EDGAR · filed Sep 11, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Aug 28, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed Aug 7, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Aug 4, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Jul 13, 2026 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Jul 1, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Jun 25, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed May 8, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed May 5, 2026 · fetched Nov 12, 2026